Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo
Julie Lagirand-Cantaloube, Karen Cornille, Alfredo Csibi et al. · 2009
Read Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo by Julie Lagirand-Cantaloube, Karen Cornille, Alfredo Csibi et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004973.txt.
Description
Muscle wasting follows bed rest, illness and starvation. A protein-shredding enzyme called Atrogin-1 drives much of that loss. Its substrates during wasting were poorly known. Julie Lagirand-Cantaloube and colleagues studied one target in PLOS ONE in 2009. The target is MyoD. MyoD controls muscle stem cell function and specialization.
Atrogin-1 tags MyoD for destruction by the proteasome. Blocking Atrogin-1 protected MyoD in living mice. With MyoD spared, skeletal muscle atrophy was prevented. The study flags the shredder as a drug target. Stopping it might protect patients whose muscles waste away during illness or immobility.
Catalog record
| CREATOR | Julie Lagirand-Cantaloube, Karen Cornille, Alfredo Csibi et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004973